Getagraph.com logo
S&P 500
(0.32%) 5 116.17 points
Dow Jones
(0.38%) 38 386 points
Nasdaq
(0.35%) 15 983 points
Oil
(-1.34%) $82.73
Gas
(6.55%) $2.05
Gold
(0.01%) $2 347.50
Silver
(-0.35%) $27.44
Platinum
(4.08%) $959.75
USD/EUR
(-0.20%) $0.933
USD/NOK
(-0.31%) $10.99
USD/GBP
(-0.54%) $0.796
USD/RUB
(1.55%) $93.30

Aktualne aktualizacje dla NeuroMetrix Inc [NURO]

Giełda: NASDAQ Sektor: Healthcare Branża: Medical Devices
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 14.14%

Ostatnio aktualizowano29 bal. 2024 @ 23:00
25% discount on Stockinvest.us - Use code: Podcast

5.86% $ 4.70

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 23:00):

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico...

Stats
Dzisiejszy wolumen 8 197.00
Średni wolumen 50 182.00
Kapitalizacja rynkowa 9.34M
EPS $0 ( 2024-02-22 )
Następna data zysków ( $0 ) 2024-05-01
Last Dividend $1 728.00 ( 2007-03-28 )
Next Dividend $0 ( N/A )
P/E -0.750
ATR14 $0.0460 (0.98%)
Insider Trading
Date Person Action Amount type
2024-04-18 Horowitz Joshua Buy 16 438 Common Stock
2024-04-18 Horowitz Joshua Buy 0 Common Stock
2024-04-18 Horowitz Joshua Sell 0 Common Stock
2024-04-01 Higgins Thomas T Buy 469 Common Stock
2024-04-01 Higgins Thomas T Sell 74 Common Stock
INSIDER POWER
54.21
Last 97 transactions
Buy: 971 558 | Sell: 254 579

NeuroMetrix Inc Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NeuroMetrix Inc Finanse

Annual 2023
Przychody: $5.90M
Zysk brutto: $3.95M (66.89 %)
EPS: $-6.27
FY 2023
Przychody: $5.90M
Zysk brutto: $3.95M (66.89 %)
EPS: $-6.27
FY 2022
Przychody: $8.26M
Zysk brutto: $5.75M (69.65 %)
EPS: $-4.90
FY 2021
Przychody: $8.25M
Zysk brutto: $5.92M (71.75 %)
EPS: $-0.342

Financial Reports:

No articles found.

NeuroMetrix Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

NeuroMetrix Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $1 728.00 2007-03-28
Last Dividend $1 728.00 2007-03-28
Next Dividend $0 N/A
Payout Date 2007-04-13
Next Payout Date N/A
# dividends 1 --
Total Paid Out $1 728.00 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-04-29)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2007 $1.000 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1.0831.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.2981.200-9.95-10.00[0 - 0.3]
returnOnEquityTTM-0.3071.500-4.52-6.78[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM16.810.80010.008.00[1 - 3]
quickRatioTTM14.920.80010.008.00[0.8 - 2.5]
cashRatioTTM1.3961.5003.365.03[0.2 - 2]
debtRatioTTM0.0112-1.5009.81-10.00[0 - 0.6]
interestCoverageTTM52.631.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
freeCashFlowPerShareTTM-4.112.00-2.06-4.11[0 - 20]
debtEquityRatioTTM0.0120-1.5009.95-10.00[0 - 2.5]
grossProfitMarginTTM0.6691.0002.192.19[0.2 - 0.8]
operatingProfitMarginTTM-1.2121.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-25.261.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.2750.800-1.497-1.198[0.5 - 2]
Total Score-0.253

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.0591.000-0.2080[1 - 100]
returnOnEquityTTM-0.3072.50-2.90-6.78[0.1 - 1.5]
freeCashFlowPerShareTTM-4.112.00-1.370-4.11[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.03611.500-3.570[0.5 - 2]
operatingCashFlowSalesRatioTTM-1.0311.000-10.000[0.1 - 0.5]
Total Score-2.82

NeuroMetrix Inc

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej